Valuation : Mayinglong Pharmaceutical Group Co., LTD.

Market Cap 9.94B 1.48B 1.27B 1.2B 1.1B 2.05B 140B 2.05B 14.16B 5.5B 71.72B 5.56B 5.44B 231B P/E 2026 *
14.9x
P/E 2027 * 13.4x
Enterprise Value 9.94B 1.48B 1.27B 1.2B 1.1B 2.05B 140B 2.05B 14.16B 5.5B 71.72B 5.56B 5.44B 231B EV / Sales 2026 *
2.37x
EV / Sales 2027 * 2.16x
Free-Float
64.65%
Yield 2026 *
-
Yield 2027 * -
1 week-1.41%
Current month+0.13%
1 month-6.41%
3 months-1.11%
6 months-11.58%
Current year-17.64%
1 week 22.89
Extreme 22.89
23.44
1 month 22.4
Extreme 22.4
24.07
Current year 21.22
Extreme 21.22
29.22
1 year 21.22
Extreme 21.22
30.18
3 years 20.2
Extreme 20.2
31.46
5 years 17.99
Extreme 17.99
33.34
10 years 12.52
Extreme 12.52
33.54
Manager TitleAgeSince
Chief Executive Officer 48 2019-05-27
Director of Finance/CFO 49 2023-12-27
Corporate Officer/Principal 40 2021-08-18
Director TitleAgeSince
Chairman 64 2010-03-15
Director/Board Member 48 2019-05-27
Director/Board Member 40 2022-06-13
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-1.41%-13.54%+3.59% 1.48B
-0.88%-2.15%+54.71%+106.31% 1,034B
-1.15%+2.68%+53.97%+71.50% 671B
-1.44%+0.38%+20.40%+73.05% 460B
+0.14%-0.47%+29.49%+38.56% 353B
-1.33%+4.72%+24.69%+45.55% 309B
-1.15%+0.30%-1.49%+12.31% 255B
-1.55%+1.11%+56.10%+70.32% 240B
-0.88%+1.15%-17.09%-54.39% 207B
-0.15%+3.65%+33.90%+96.99% 188B
Average -0.89%+1.00%+24.11%+46.38% 371.82B
Weighted average by Cap. -1.10%+0.51%+36.60%+66.18%

Financials

2026 *2027 *
Net sales 4.2B 625M 538M 506M 463M 865M 59.05B 868M 5.98B 2.32B 30.29B 2.35B 2.3B 97.59B 4.61B 686M 590M 555M 507M 949M 64.77B 952M 6.56B 2.55B 33.23B 2.58B 2.52B 107B
Net income 668M 99.43M 85.56M 80.5M 73.53M 138M 9.39B 138M 951M 369M 4.82B 373M 365M 15.52B 740M 110M 94.78M 89.18M 81.46M 152M 10.4B 153M 1.05B 409M 5.34B 414M 405M 17.19B
Net Debt - -
Logo Mayinglong Pharmaceutical Group Co., LTD.
Mayinglong Pharmaceutical Group Co Ltd is a China-based company mainly engaged in the production and sale of anorectal health products. The Company operates three segments. The Pharmaceutical Industry segment is mainly engaged in the development, production and sale of pharmaceuticals and health products. The Pharmaceutical Commerce segment is mainly engaged in the retail and wholesale of medical devices and pharmaceuticals. The Hospital Diagnosis and Treatment segment is mainly engaged in hospital medical services and management. The Company mainly conducts businesses within the domestic market.
Employees
2,544
Date Price Change Volume
26-09-04 CN¥23.06 0.00% 2,667,400
26-09-03 CN¥23.06 -0.22% 1,961,514
26-09-02 CN¥23.11 -0.43% 3,101,914
26-09-01 CN¥23.21 +0.78% 2,777,910
26-08-31 CN¥23.03 -1.54% 3,438,178
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
23.06CNY
Average target price
37.74CNY
Spread / Average Target
+63.68%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 600993 Stock